Cargando…
Serum Levels of the Adipokine Zinc-α2-glycoprotein Are Decreased in Patients with Hypertension
Objective. Zinc-α2-glycoprotein (ZAG) has recently been proposed as a new adipokine involved in body weight regulation. The purpose of this study is to investigate serum levels of ZAG in patients with hypertension and its association with related characteristics. Methods. 32 hypertension patients an...
Autores principales: | Zhu, Hui Juan, Wang, Xiang qing, Pan, Hui, Gong, Feng ying, Zhang, Dian xi, Li, Nai shi, Wang, Lin jie, Yang, Hong bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934454/ https://www.ncbi.nlm.nih.gov/pubmed/24665369 http://dx.doi.org/10.1155/2014/374090 |
Ejemplares similares
-
Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease
por: Liu, Meijuan, et al.
Publicado: (2019) -
Inhibition of preadipocyte differentiation and adipogenesis by zinc‐α2‐glycoprotein treatment in 3T3‐L1 cells
por: Zhu, Hui‐Juan, et al.
Publicado: (2013) -
Zinc and the Innovative Zinc-α2-Glycoprotein Adipokine Play an Important Role in Lipid Metabolism: A Critical Review
por: Banaszak, Michalina, et al.
Publicado: (2021) -
Serum Zinc-α2-Glycoprotein Levels in Patients with or without Coronary Artery Disease in Chinese North Population
por: Liu, Meijuan, et al.
Publicado: (2020) -
Zinc-α2-Glycoprotein Is Associated with Obesity in Chinese People and HFD-Induced Obese Mice
por: Liu, Meijuan, et al.
Publicado: (2018)